Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4 vs 20 injection sites of OnabotulinumtoxinA for OAB
NCT05157295Phase 4Unknown
- Sponsor
- Augusta University
- Start
- Jan 2022
- Primary completion
- Sep 2022
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of botulinum toxin type A in overactive bladder syndrome (OAB), sponsored by Augusta University. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
overactive bladder syndrome (OAB)
Beyond the preview
Go deeper on NCT05157295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05157295.